Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Ocular Therapeutix Announced That Executive Chairman, Pravin Dugel, Is Assuming The Roles Of President And CEO And That Antony Mattessich Is Stepping Down As President And CEO, Effective Immediately

Author: Benzinga Newsdesk | April 15, 2024 07:27am

Posted In: OCUL

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist